Identification of new miRNA biomarkers associated with HER2-positive breast cancers
Open Access
- 1 October 2015
- journal article
- Published by Impact Journals, LLC in Oncoscience
- Vol. 2 (11) , 924-929
Abstract
Human epidermal growth factor receptor 2 (HER2) is overexpressed/amplified in ∼30% breast cancers which are associated with poor prognosis. microRNAs are small non-coding RNA which play an important role in many physiological conditions including cancer. Here we screened and identified many miRNAs which are dysregulated by HER2 overexpression. In line with our quantitative PCR analysis data, in silico analysis of microRNA expression profiles of 1302 breast tumors revealed that miR-146a-5p is up-regulated and miR-181d and miR-195-5p are down-regulated in HER2-positive tumors. Furthermore, the expression levels of these microRNAs can significantly predict patient survival and thus potentially serve as new prognostic markers for HER2-positive breast cancer.Keywords
This publication has 25 references indexed in Scilit:
- The shaping and functional consequences of the microRNA landscape in breast cancerNature, 2013
- miR-146a Inhibits Cell Growth, Cell Migration and Induces Apoptosis in Non-Small Cell Lung Cancer CellsPLOS ONE, 2013
- CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin–TGFβ signalingOncogene, 2011
- Her2 activates NF-κB and induces invasion through the canonical pathway involving IKKαOncogene, 2009
- MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neureceptor status in breast cancerBreast Cancer Research, 2009
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- Expression of microRNA-146 suppresses NF-κB activity with reduction of metastatic potential in breast cancer cellsOncogene, 2008
- NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responsesProceedings of the National Academy of Sciences, 2006
- MicroRNA Gene Expression Deregulation in Human Breast CancerCancer Research, 2005
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences, 2001